These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 11584892)

  • 1. Ex vivo pediatric brain tumors express Fas (CD95) and FasL (CD95L) and are resistant to apoptosis induction.
    Riffkin CD; Gray AZ; Hawkins CJ; Chow CW; Ashley DM
    Neuro Oncol; 2001 Oct; 3(4):229-40. PubMed ID: 11584892
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Carboplatin induces Fas (APO-1/CD95)-dependent apoptosis of human tongue carcinoma cells: sensitization for apoptosis by upregulation of FADD expression.
    Mishima K; Nariai Y; Yoshimura Y
    Int J Cancer; 2003 Jul; 105(5):593-600. PubMed ID: 12740905
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fas ligand is expressed in normal breast epithelial cells and is frequently up-regulated in breast cancer.
    Müllauer L; Mosberger I; Grusch M; Rudas M; Chott A
    J Pathol; 2000 Jan; 190(1):20-30. PubMed ID: 10640988
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FK506 restores sensitivity of thymic lymphomas to calcium-mediated apoptosis and the inducible expression of Fas ligand.
    Kalas W; Matuszyk J; Ziolo E; Strzadala L
    Anticancer Res; 2003; 23(2B):1613-7. PubMed ID: 12820430
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human pancreatic adenocarcinomas express Fas and Fas ligand yet are resistant to Fas-mediated apoptosis.
    Ungefroren H; Voss M; Jansen M; Roeder C; Henne-Bruns D; Kremer B; Kalthoff H
    Cancer Res; 1998 Apr; 58(8):1741-9. PubMed ID: 9563493
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thyroid carcinoma cells are resistant to FAS-mediated apoptosis but sensitive to tumor necrosis factor-related apoptosis-inducing ligand.
    Mitsiades N; Poulaki V; Tseleni-Balafouta S; Koutras DA; Stamenkovic I
    Cancer Res; 2000 Aug; 60(15):4122-9. PubMed ID: 10945619
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of apoptosis in wild-type and Fas-resistant cells: chemotherapy-induced apoptosis is not dependent on Fas/Fas ligand interactions.
    Eischen CM; Kottke TJ; Martins LM; Basi GS; Tung JS; Earnshaw WC; Leibson PJ; Kaufmann SH
    Blood; 1997 Aug; 90(3):935-43. PubMed ID: 9242521
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Up-regulation of Fas (APO-1/CD95) ligand and down-regulation of Fas expression in human esophageal cancer.
    Gratas C; Tohma Y; Barnas C; Taniere P; Hainaut P; Ohgaki H
    Cancer Res; 1998 May; 58(10):2057-62. PubMed ID: 9605741
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The CD95/CD95 ligand system is not the major effector in anticancer drug-mediated apoptosis.
    Tolomeo M; Dusonchet L; Meli M; Grimaudo S; D'Alessandro N; Papoff G; Ruberti G; Rausa L
    Cell Death Differ; 1998 Sep; 5(9):735-42. PubMed ID: 10200532
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of Fas-mediated apoptosis in a human renal epithelial cell line by interferon-gamma: involvement of Fas-mediated apoptosis in acute renal rejection.
    Akasaka Y; Ishikawa Y; Kato S; Ishii T; Masuda T; Fujita K; Yamada T; Kawamura S
    Mod Pathol; 1998 Nov; 11(11):1107-14. PubMed ID: 9831209
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of vitamin K2 on osteoblast apoptosis: vitamin K2 inhibits apoptotic cell death of human osteoblasts induced by Fas, proteasome inhibitor, etoposide, and staurosporine.
    Urayama S; Kawakami A; Nakashima T; Tsuboi M; Yamasaki S; Hida A; Ichinose Y; Nakamura H; Ejima E; Aoyagi T; Nakamura T; Migita K; Kawabe Y; Eguchi K
    J Lab Clin Med; 2000 Sep; 136(3):181-93. PubMed ID: 10985496
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The CD95 (APO-1/Fas) system mediates drug-induced apoptosis in neuroblastoma cells.
    Fulda S; Sieverts H; Friesen C; Herr I; Debatin KM
    Cancer Res; 1997 Sep; 57(17):3823-9. PubMed ID: 9288794
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of the oncogenic NPM-ALK chimeric protein in human lymphoid T-cells inhibits drug-induced, but not Fas-induced apoptosis.
    Greenland C; Touriol C; Chevillard G; Morris SW; Bai R; Duyster J; Delsol G; Allouche M
    Oncogene; 2001 Nov; 20(50):7386-97. PubMed ID: 11704868
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modification of tumor cells with Fas (CD95) antigen gene and Fas ligand (CD95L) gene transfection by electroporation for immunotherapy of cancer.
    Shimizu M; Yoshimoto T; Matsuzawa A; Takeda Y
    Mol Biotechnol; 2003 Sep; 25(1):79-87. PubMed ID: 13679638
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ex vivo malignant glioma cells are sensitive to Fas (CD95/APO-1) ligand-mediated apoptosis.
    Frei K; Ambar B; Adachi N; Yonekawa Y; Fontana A
    J Neuroimmunol; 1998 Jul; 87(1-2):105-13. PubMed ID: 9670851
    [TBL] [Abstract][Full Text] [Related]  

  • 16. On the role and significance of Fas (Apo-1/CD95) ligand (FasL) expression in immune privileged tissues and cancer cells using multiple myeloma as a model.
    Greil R; Egle A; Villunger A
    Leuk Lymphoma; 1998 Nov; 31(5-6):477-90. PubMed ID: 9922038
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of Fas (APO-1/CD95) and Fas ligand (FasL) in human neuroblastoma.
    Gross N; Balmas K; Beretta Brognara C; Tschopp J
    Med Pediatr Oncol; 2001 Jan; 36(1):111-4. PubMed ID: 11464860
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of antitumor immunity with Fas/APO-1 ligand (CD95L)-transfected neuroblastoma neuro-2a cells.
    Shimizu M; Fontana A; Takeda Y; Yagita H; Yoshimoto T; Matsuzawa A
    J Immunol; 1999 Jun; 162(12):7350-7. PubMed ID: 10358186
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fas ligand is expressed on human squamous cell carcinomas of the head and neck, and it promotes apoptosis of T lymphocytes.
    Gastman BR; Atarshi Y; Reichert TE; Saito T; Balkir L; Rabinowich H; Whiteside TL
    Cancer Res; 1999 Oct; 59(20):5356-64. PubMed ID: 10537320
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential involvement of the CD95 (Fas/APO-1) receptor/ligand system on apoptosis induced by the wild-type p53 gene transfer in human cancer cells.
    Fukazawa T; Fujiwara T; Morimoto Y; Shao J; Nishizaki M; Kadowaki Y; Hizuta A; Owen-Schaub LB; Roth JA; Tanaka N
    Oncogene; 1999 Apr; 18(13):2189-99. PubMed ID: 10327065
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.